-
PurposeExpresses shRNA against human Drp1 from puromycin resistance retroviral vector
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 99385 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
This material is available to academics and nonprofits only.
Backbone
-
Vector backbonepSuper-Retro-Puro
-
Backbone manufacturerOligoengine
- Backbone size w/o insert (bp) 6313
- Total vector size (bp) 6374
-
Vector typeRetroviral, RNAi
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameDynamin-1-like protein
-
Alt nameDrp1
-
gRNA/shRNA sequenceCAGGAGCCAGCTAGATATTAA
-
SpeciesH. sapiens (human)
-
GenBank IDNM_012062
-
Entrez GeneDNM1L (a.k.a. DLP1, DRP1, DVLP, DYMPLE, EMPF, EMPF1, HDYNIV, OPA5)
- Promoter H1
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII (destroyed during cloning)
- 3′ cloning site HindIII (not destroyed)
- 5′ sequencing primer GGAAGCCTTGGCTTTTG
- 3′ sequencing primer CGAACGCTGACGTCATC (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The shRNA target sequence employed in this vector was first identified and used in: Friedman, etal. Science 2011, 334, 358–362. (www.ncbi.nlm.nih.gov/pubmed/21885730)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSuper-Retro-Puro-Drp1-shRNA was a gift from David Kashatus (Addgene plasmid # 99385 ; http://n2t.net/addgene:99385 ; RRID:Addgene_99385) -
For your References section:
Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. Kashatus JA, Nascimento A, Myers LJ, Sher A, Byrne FL, Hoehn KL, Counter CM, Kashatus DF. Mol Cell. 2015 Feb 5;57(3):537-51. doi: 10.1016/j.molcel.2015.01.002. 10.1016/j.molcel.2015.01.002 PubMed 25658205